Volume 11 Supplement 1

5th International Conference on cGMP: Generators, Effectors and Therapeutic Implications

Open Access

Inhibitors of the phosphodiesterase 2 increased axonal fibre growth in a dopaminergic organotypic ex vivo slice co-culture model

  • Claudia Heine1, 2,
  • Nico Scherf1,
  • Katja Sygnecka1, 2,
  • Ute Egerland3Email author,
  • Thorsten Hage3 and
  • Heike Franke2
BMC Pharmacology201111(Suppl 1):P34

https://doi.org/10.1186/1471-2210-11-S1-P34

Published: 1 August 2011

Background

Due to the necessity for therapeutic strategies promoting neuro-(re)generation the development of appropriate models appraising the potential of substances for regeneration and repair of neuronal circuits are of great importance. Here we present a procedure for the quantification of fibre outgrowth on the basis of organotypic slice co-cultures of the dopaminergic projection system, appropriate for characterising the effects on axonal growth after treatment with well known controls and growth factors e.g. nerve growth factor (NGF) and new drug candidates. Therefore co-culture preparations were used, consisting of at least two slices of different parts of the brain, namely the ventral tegmental area/substantia nigra (VTA/SN) and the striatum (STR), whereas while incubation fibres projections regenerate and new connections were built, linking the two slices [1, 2].

Results

Utilizing immunohistochemistry in combination with laser scanning microscopy the outgrowing fibres in the border region of the VTA/SN-STR co-cultures were identified as microtubule associated protein-2 (MAP2)-, βIII-Tubulin- and tyrosine hydroxylase (TH)-positive. Furthermore the expression of phosphodiesterase (PDE) - 2A on cell bodies and fibres was revealed within the VTA/SN and STR. To expose the effect of the applied compounds on fibre outgrowth we developed a treatment protocol followed by tracing techniques and computerised quantification procedure. Thus we were able to quantify the fibre density together with detailed qualitative information about the growth characteristics of single fibres. Here we present recent data on stimulation studies using different phosphodiesterase (PDE) 2 inhibitors in comparison to NGF as well as control conditions. The incubation with the PDE2-inhibitor BAY 60-7550, ND 7001 and BTT5001 induced a significant increase of the fibre density in the border region of VTA/SN-STR co-cultures. The potential was comparable with the effect evoked by NGF. The involvement of PDE2 in fibre growth has been shown, suggesting an outgrowth promoting effect of PDE2 inhibitors. This is also supported by the elevation of intracellular cGMP upon inhibition of PDE2.

Conslusion

The introduced ex vivo model of organotypic slice co-cultures provides a valuable tool to assess the therapeutic potential of drug candidates for regeneration and repair of disrupted neuronal circuits.

Declarations

Acknowledgements

The authors thank Katrin Becker, Katrin Krause (Rudolf Boehm Institute of Pharmacology and Toxicology) for technical assistance.

The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 0315883) and SAB grant (12525).

Authors’ Affiliations

(1)
Translational Center for Regenerative Medicine (TRM), University of Leipzig
(2)
Rudolf Boehm Institute of Pharmacology and Toxicology, University of Leipzig
(3)
Biocrea

References

  1. Franke H, Schelhorn N, Illes P: Dopaminergic neurons develop axonal projections to their target areas in organotypic co-cultures of the ventral mesencephalon and the striatum/prefrontal cortex. Neurochem Int. 2003, 42: 431-439. 10.1016/S0197-0186(02)00134-1.View ArticlePubMedGoogle Scholar
  2. Heine C, Wegner A, Grosche J, Allgaier C, Illes P, Franke H: P2 receptor expression in the dopaminergic system of the rat brain during development. Neuroscience. 2007, 149: 165-181. 10.1016/j.neuroscience.2007.07.015.View ArticlePubMedGoogle Scholar

Copyright

© Heine et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement